This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ots Medical Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Assaf Dekel: Innovator in Shoulder-Joint Repair
Introduction
Assaf Dekel is a notable inventor based in Savyon, Israel. He has made significant contributions to the field of medical technology, particularly in the area of shoulder-joint repair. With a total of 2 patents to his name, Dekel's work focuses on innovative solutions for treating bone lesions.
Latest Patents
One of Dekel's latest patents involves the repair of shoulder-joint lesions. This invention relates to bone-implants designed for treating lesions on bones. The patent describes a system that includes a bone anchor, a container in communication with the bone anchor, and an osteoconductive bone-filler material inside the container. This innovative approach aims to enhance the healing process for patients suffering from shoulder injuries.
Career Highlights
Assaf Dekel is currently associated with Ots Medical Ltd., where he continues to develop groundbreaking medical technologies. His expertise in the field has positioned him as a key player in advancing treatments for orthopedic conditions.
Collaborations
Dekel collaborates with various professionals in the medical field, including his coworker Nir Lilach. Together, they work towards improving patient outcomes through innovative medical solutions.
Conclusion
Assaf Dekel's contributions to the field of shoulder-joint repair exemplify the impact of innovation in medical technology. His patents reflect a commitment to enhancing treatment options for patients, showcasing the importance of continued research and development in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile